Skip to main content
European Commission logo print header

from gold to silver: streamlining metal-catalysed cross-coupling reactions

Objetivo

Silvercatpharma project aims at developing C-C cross-coupling reactions catalysed by d11-blocks metals, particularly silver, for the synthesis of pharmaceuticals in Novartis. It strives to have an impact in terms of cost, environment and international visibility because of the use of silver as an alternative catalyst. The project offers me a great opportunity to obtain further training, such as clusters preparation, computational and flow chemistry, and to define my final career in academia or industry because of the possibility of working in these two different environments.

Régimen de financiación

MSCA-IF-EF-ST - Standard EF

Coordinador

FUNDACIO PRIVADA INSTITUT CATALA D'INVESTIGACIO QUIMICA
Aportación neta de la UEn
€ 158 121,60
Dirección
AVENIDA PAISSOS CATALANS 16
43007 Tarragona
España

Ver en el mapa

Región
Este Cataluña Tarragona
Tipo de actividad
Research Organisations
Enlaces
Coste total
€ 158 121,60